Page last updated: 2024-10-25

cifenline and Constriction, Pathological

cifenline has been researched along with Constriction, Pathological in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Hypertrophic cardiomyopathy is a common cardiac complication in mitochondrial disorders, and the morbidity rate in neonatal cases is up to 40%."1.72A Case of Infantile Mitochondrial Cardiomyopathy Treated with a Combination of Low-Dose Propranolol and Cibenzoline for Left Ventricular Outflow Tract Stenosis. ( Kishita, Y; Kono, Y; Miyauchi, A; Murayama, K; Okazaki, Y; Omika, N; Osaka, H; Sato, T; Shimozawa, H; Takeda, A; Yada, Y; Yamagata, T, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shimozawa, H1
Sato, T1
Osaka, H1
Takeda, A1
Miyauchi, A1
Omika, N1
Yada, Y1
Kono, Y1
Murayama, K1
Okazaki, Y1
Kishita, Y1
Yamagata, T1

Other Studies

1 other study available for cifenline and Constriction, Pathological

ArticleYear
A Case of Infantile Mitochondrial Cardiomyopathy Treated with a Combination of Low-Dose Propranolol and Cibenzoline for Left Ventricular Outflow Tract Stenosis.
    International heart journal, 2022, Sep-30, Volume: 63, Issue:5

    Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Constriction, Pathologic; Humans; Imidazoles;

2022